Market News

Key Developments

Research and development related to the diagnosis and treatment of ovarian cancer is expected to offer lucrative opportunities for market players. For instance, in August 2019, researchers from The George Washington University School of Medicine and Health Sciences, U.S. identified ovarian cancer drug resistance protein that needs to be blocked for the treatment of patients with platinum-resistant ovarian cancer.

Moreover, in July 2019, researchers from the University College London, in collaboration with research centers in Germany, Italy, Norway, and the Czech Republic, found a link between lower levels of lactobacilli in the vagina and the presence of ovarian cancer or BRCA1 mutations in women aged under 50.

Similarly, in February 2018, researchers from Roswell Park Cancer Institute in Buffalo, New York, found that paternal genes may influence ovarian cancer risk.